longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Mustang Bio

MBIO

0.46181.16% ( -0.0054 )
Trading: Oct 2, 14:13:47 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -1.17, within the reasonable range, cheaper than 65.39% of the time in the past 5 years, and the industry ranks 206/602, the industry Median -2.12.

-1.17xP/E
$0.47Stock price
$-0.40Earnings per share
-1.17xP/E
Stock price$0.47Earnings per share$-0.40

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.72x
Typical range
-2.50x–-0.27x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
019385776

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-56.45x148.77%$182.89B
MRNAUSModerna
-23.94x15.53%$75.43B
CSLLYUSCSL Limited
-22.98x--$59.27B
NTRAUSNatera
-306.11x6.91%$58.88B
RVMDUSRevolution Medicines
-24.96x63.01%$44.13B
ROIVUSRoivant Sciences
-96.31x146.49%$25.64B
BNTXUSBioNTech SE
-12.43x17.09%$24.33B
INSMUSInsmed
-27.09x74.61%$23.71B
SMMTUSSummit Therapeutics
-15.55x19.67%$13.31B
BBIOUSBridgebio Pharma
-18.91x28.48%$13.08B
TWSTUSTwist Bioscience
-90.55x20.00%$12.38B
MDGLUSMadrigal Pharma
-35.51x51.06%$11.55B
IBRXUSImmunityBio
-9.91x152.63%$9.84B
KYMRUSKymera Therapeutics
-30.56x4.94%$9.16B
ARWRUSArrowHead Pharma
-28.60x36,308.30%$9.15B
CYTKUSCytokinetics
-10.20x6.37%$9.12B
PCVXUSVaxcyte
-7.84x48.80%$8.34B
ABVXUSAbivax SA
-17.80x22.49%$8.29B
PRAXUSPraxis Precision Medicines
-23.62x3.05%$8.01B
SYREUSSpyre Therapeutics
-52.79x46.89%$7.93B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.